Cannabis is ready to find its spot in the $1.2 trillion pharmaceutical industry…

Editor’s Note: Advisory Board member Michael A. Robinson is a 35-year Silicon Valley veteran and one of the top technology financial analysts working today. And he has a special report this month that he wanted to make sure all members of the National Institute for Cannabis Investors could access…

The legalization of cannabis will probably go down in history as one of the greatest advancements in medical history. I’m talking about a discovery as powerful as penicillin or learning how germs cause diseases.

With cannabis, the world of medicine has a real wonder drug on its hands.

I’ve said it before, but it’s worth saying again. Cannabis is the world’s only universal drug because the human body is specifically wired to accept it.

To put this in more precise terms, cannabis has been identified as a potential treatment for no less than 172 different medical conditions.

There may well be more.

Already, though, we know that the conditions that can be treated with the help of cannabis include severe and notorious diseases like cancer, multiple sclerosis, glaucoma, epilepsy, and chronic pain.

Looking at these sectors of the pharmaceutical industry in terms of market size shows us that medical cannabis has plenty of room to expand.

And as it expands, it’s building a new wave of wealth for investors…

Medical Cannabis Disrupting Big Pharma Will Generate Billions

According to Allied Market Research, the annual market for cancer and oncology drugs alone will reach $ 176.5 billion by 2025.

This self-made marijuana millionaire is divulging the three simple steps he used to create his cannabis fortune. See for yourself right here.

Transparency Market Research projects that multiple sclerosis treatment will grow to a $31.5 billion market size by 2027. The market for glaucoma treatment is another $8 billion.

And in this special report, you can see just how big I think the market is for treating medical conditions with cannabis.

Just click here for my full report.

Until next time,

Michael Robinson

Advisory Board Member, National Institute for Cannabis Investors

P.S. Legendary quarterback Joe Montana has a long history of making some dynamite investing decisions. Through his investment fund, he even backed giants like Dropbox and Pinterest before they exploded onto the scene. Now one of the sectors he has his eye on is the cannabis market. In fact, he recently sat down with three of the brightest minds in cannabis to talk about the hottest trends in the industry this year. And Joe’s #1 pick? Medical cannabis. You’re not going to want to miss this event. Click here now for unrestricted access.


Comments

6 responses to “Cannabis Is Taking on the $1.2 Trillion Pharmaceutical Market”

  1. don’t know anything about the stock market ,,, so how do i get started in buying stock
    like cannabis and how much money do i need to start with.

    • Hi Phil,

      To start you will need to open a brokerage account.

      These are some of the brokerages our members use and their customer service numbers are included to help you get started:
      eTrade 1 (800) 387-2331
      Fidelity – 1 (800) 343-3548
      TDAmeritrade – 1 (800) 669-3900

      Robinhood is also very easy to use, but it does not have all of the cannabis stocks we trade. But it is free to set up an account.

      You can also check out this report about setting up brokerage accounts we recently released – https://nicinvestors.com/2020/03/12/how-to-set-up-a-brokerage-account/

      After that, this page is a great resource for new cannabis investors – https://nicinvestors.com/free-reports/

Leave a Reply

Your email address will not be published. Required fields are marked *